for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ibnsina Pharma Co SAE

ISPH.CA

Latest Trade

9.80EGP

Change

0.10(+1.03%)

Volume

420,112

Today's Range

9.70

 - 

9.80

52 Week Range

8.45

 - 

11.97

As of on the Egyptian Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
9.70
Open
9.75
Volume
420,112
3M AVG Volume
14.84
Today's High
9.80
Today's Low
9.70
52 Week High
11.97
52 Week Low
8.45
Shares Out (MIL)
820.00
Market Cap (MIL)
7,954.00
Forward P/E
22.05
Dividend (Yield %)
0.58

Latest Developments

More

Egypt's Ibnsina Pharma Q3 Profit Rises

Egyptian Exchange Says EBRD Reduces Stake In Ibnsina Pharma To 8.71%

Egyptian Exchange Says 69.1 Mln Shares Of Ibnsina Pharma Block Traded

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Ibnsina Pharma Co SAE

Ibnsina Pharma Co is an Egypt-based pharmaceutical distribution company. The Company distributes a portfolio of pharmaceutical products from over 350 Egyptian and multinational companies to more than 35,000 customers including pharmacies, hospitals, retail outlets, and wholesalers. Ibnsina Pharma Co's nationwide distribution network with more than 50 operational sites, including distribution hubs and central warehouses, is supported by a fleet of approximately 600 vehicles. The Company's main services for suppliers include management of warehousing and logistics for pharmaceutical products as well as the development and execution of tailored marketing solutions targeting a nationwide database of customers.

Industry

Major Drugs

Contact Info

Industrial Zone 1,

PO Box 91

+20.2.44891102

http://www.ibnsina-pharma.com/

Key Stats

1.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, EGP)

2017

9.6K

2018

13.7K

2019(E)

16.9K
EPS (EGP)

2017

0.220

2018

0.317

2019(E)

0.440
Price To Earnings (TTM)
24.87
Price To Sales (TTM)
0.50
Price To Book (MRQ)
6.98
Price To Cash Flow (TTM)
20.15
Total Debt To Equity (MRQ)
127.36
LT Debt To Equity (MRQ)
46.83
Return on Investment (TTM)
23.82
Return on Equity (TTM)
4.64

Latest News

Latest News

MIDEAST STOCKS-Saudi ends up, institutions appear to mount support operation

Saudi Arabian stocks plunged early on Tuesday on worries that the furore over the disappearance of dissident Jamal Khashoggi could damage foreign investment, but the market ended up after state-linked funds appeared to mount an operation to support it.

BRIEF-Ibnsina Pharma Signs Drug Distribution Contracts With Novo Nordisk

* SIGNS TWO CONTRACTS WITH NOVO NORDISK TO DISTRIBUTE OVER 20 STOCK-KEEPING UNITS OF ITS DIABETES CARE, HAEMOPHILIA, GROWTH DISORDERS PRODUCTS IN EGYPT Source: (http://bit.ly/2ppnnGW) Further company coverage:

BRIEF-Egypt's Ibnsina Pharma Q4 Profit Rises

* Q4 NET PROFIT EGP 49.1 MILLION VERSUS EGP 20.1 MILLION YEAR AGO

BRIEF-Egyptian Exchange Lists Ibnsina Pharma's Authorized Capital Increase

* LISTS IBNSINA PHARMA'S AUTHORIZED CAPITAL INCREASE TO EGP 1 BILLION FROM EGP 168 MILLION Source:(http://bit.ly/2CXYQkN) Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up